Dr. Sulaiman Al-Habib Medical Services Group Co.

As of June 30, 2026, Dr. Sulaiman Al-Habib Medical Services Group Co. carries a market capitalization of 74.20B, placing it among publicly traded companies globally. Its enterprise value stands at 82.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Dr. Sulaiman Al-Habib Medical Services Group Co.'s next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Dr. Sulaiman Al-Habib Medical Services Group Co. has 350.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Dr. Sulaiman Al-Habib Medical Services Group Co. maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Dr. Sulaiman Al-Habib Medical Services Group Co. recorded 41.66M in income tax expense.

As of the close on October 22, 2026, Dr. Sulaiman Al-Habib Medical Services Group Co.'s stock has declined approximately 23.11% over the past 52 weeks. The 50-day moving average sits at 229.02, while the 200-day moving average is 235.07.

As of June 30, 2026, Dr. Sulaiman Al-Habib Medical Services Group Co. holds 2.32B in cash and equivalents against 9.67B in total debt, resulting in a net debt position of 6.90B. Total book value stands at 8.26B, with working capital of 667.74M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Dr. Sulaiman Al-Habib Medical Services Group Co. paid dividends of 3.53 per share.